Why The PhytoTech Medical Limited Share Price Fell Today

What Happened to the PhytoTech Medical Share Price?

PhytoTech Medical Limited [ASX:PYL] is a newly listed Australian company. It is developing medical cannabis for the US, Canada, Israel, Europe, Australia and New Zealand.

PhytoTech Medical are developing, manufacturing and marketing a novel delivery system of medical cannabis. PhytoTech plan to bring to market a flexible mucosdhesive adhesive patch that will release the pain killing properties of marijuana in a controlled manner.

PhytoTech medical have the exclusive license for this patented product by Yissum Research Project.

Patients can take medical cannabis in a variety of methods including vaporising and smoking dried buds, eating extracts or capsules, or oral spray.

The share price closed 12.84% lower on Friday.

Why Did This Happen to PhytoTech Medical Shares?

This company has caught the market by surprise.

However the share price is volatile. Yesterday the stock closed up 9% higher to 54 cents, and today’s it’s taken a hammering.

Only six trading days in, PhytoTech Medical is already trading at more than double its 20 cent initial public offering price.

Within two days of listing, PYL shares soared to a high of 92c, before falling back to today’s closing price of 47.5 cents.

The company listed on the ASX on 22 January 2015.

What Now for PhytoTech Medical?

Already this is a tricky company to analyse.

I hit up our resident small cap expert Tim Dohrmann of Australian Small-Cap Investigator for a suggestion on what the unexpected share price activity could mean.

Tim tells me, ‘It’s one of two things. There’s either some funny business going on…or the more likely scenario is that no one actually knows what this company is worth or how to value it just yet.’

A progressive company that campaigns globally for legal use of medical marijuana may sound like an exciting investment to be part of.

However the volatility of the stock suggests that it may be too early to invest in it for now.

Shae Smith
Editor, Money Weekend

Join Money Morning on Google+

Since starting out in the financial markets over a decade ago, Shae has extensive experience across various aspects of the industry. Shae cut her teeth in the derivatives industry, teaching clients basic trading techniques with technical analysis.

Joining Fat Tail Investment Research eight years ago, Shae has worked across a number of publications, such as Australian Small-Cap Investigator, Gold Stock Trader and Microcap Trader. She’s spent the past two years however, honing her macro analysis skills alongside Jim Rickards, showing Australians how to invest and profit form global macro trends.

Drawing on her extensive experience, Shae is a contributor to Money Morning, and lead editor of sister-publication Markets & Money, where she looks at broad macro trends developing around the world, combining them with her distaste for central banks and irrational love of all things bullion.

Money Morning Australia